Authors:
Lodder, L
Frets, PG
Trijsburg, RW
Tibben, A
Meijers-Heijboer, EJ
Duivenvoorden, HJ
Wagner, A
van der Meer, CA
Devilee, P
Cornelisse, CJ
Niermeijer, MF
Citation: L. Lodder et al., Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing, EUR J HUM G, 9(7), 2001, pp. 492-500
Authors:
Brekelmans, CTM
Seynaeve, C
Bartels, CCM
Tilanus-Linthorst, MMA
Meijers-Heijboer, EJ
Crepin, CMG
van Geel, AN
Menke, M
Verhoog, LC
van den Ouweland, A
Obdeijn, IM
Klijn, JGM
Citation: Ctm. Brekelmans et al., Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk, J CL ONCOL, 19(4), 2001, pp. 924-930
Authors:
Lodder, L
Frets, PG
Trijsburg, RW
Meijers-Heijboer, EJ
Klijn, JGM
Duivenvoorden, HJ
Tibben, A
Wagner, A
van der Meer, CA
van den Ouweland, AMW
Niermeijer, MF
Citation: L. Lodder et al., Psychological impact of receiving a BRCA1/BRCA2 test result, AM J MED G, 98(1), 2001, pp. 15-24
Authors:
Wagner, A
Hendriks, Y
Meijers-Heijboer, EJ
de Leeuw, WJF
Morreau, H
Hofstra, R
Tops, C
Bik, E
Brocker-Vriends, AHJT
van der Meer, C
Lindhout, D
Vasen, HFA
Breuning, MH
Cornelisse, CJ
van Krimpen, C
Niermeijer, MF
Zwinderman, AH
Wijnen, J
Fodde, R
Citation: A. Wagner et al., Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutchpedigree, J MED GENET, 38(5), 2001, pp. 318-322
Authors:
Verhoog, LC
Berns, EMJJ
Brekelmans, CTM
Seynaeve, C
Meijers-Heijboer, EJ
Klijn, JGM
Citation: Lc. Verhoog et al., Prognostic significance of germline BRCA2 mutations in hereditary breast cancer patients, J CL ONCOL, 18(21), 2000, pp. 119S-124S
Authors:
Meijers-Heijboer, EJ
Verhoog, LC
Brekelmans, CTM
Seynaeve, C
Tilanus-Linthorst, MMA
Wagner, A
Dukel, L
Devilee, P
van den Ouweland, AMW
van Geel, AN
Klijn, JGM
Citation: Ej. Meijers-heijboer et al., Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation, LANCET, 355(9220), 2000, pp. 2015-2020
Citation: Ln. Lodder et al., Attitudes towards termination of pregnancy in subjects who underwent presymptomatic testing for the BRCA1/BRCA2 gene mutation in The Netherlands, J MED GENET, 37(11), 2000, pp. 883-884
Authors:
Meijers-Heijboer, EJ
Verhoog, LC
Brekelmans, CTM
Seynaeve, C
Tilanus-Linthorst, MMA
Wagner, A
Dukel, L
Devilee, P
van den Ouweland, AMW
van Geel, AN
Klijn, JGM
Citation: Ej. Meijers-heijboer et al., Genetic testing and prophylactic surgery in familiar clusters of BRCA1 or BRCA2 mutation, GYNAKOLOGE, 33(10), 2000, pp. 768-769
Authors:
Verhoog, LC
Brekelmans, CTM
Seynaeve, C
Meijers-Heijboer, EJ
Klijn, JGM
Citation: Lc. Verhoog et al., Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer, BR J CANC, 83(3), 2000, pp. 384-386
Authors:
Verhoog, LC
Brekelmans, CTM
Seynaeve, C
Dahmen, G
van Geel, AN
Bartels, CCM
Tilanus-Linthorst, MMA
Wagner, A
Devilee, P
Halley, DJJ
van den Ouweland, AMW
Meijers-Heijboer, EJ
Klijn, JGM
Citation: Lc. Verhoog et al., Survival in hereditary breast cancer associated with germline mutations ofBRCA2, J CL ONCOL, 17(11), 1999, pp. 3396-3402
Authors:
Lodder, LN
Frets, PG
Trijsburg, RW
Meijers-Heijboer, EJ
Klijn, JGM
Duivenvoorden, HJ
Tibben, A
Wagner, A
van der Meer, CA
Devilee, P
Cornelisse, CJ
Niermeijer, MF
Citation: Ln. Lodder et al., Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks?, J MED GENET, 36(12), 1999, pp. 906-913